Craig Tendler - 12 Feb 2026 Form 4 Insider Report for TuHURA Biosciences, Inc./NV (HURA)

Role
Director
Signature
/s/ Dan Dearborn as Power of Attorney for Craig Tendler
Issuer symbol
HURA
Transactions as of
12 Feb 2026
Net transactions value
$0
Form type
4
Filing time
17 Feb 2026, 16:21:30 UTC
Previous filing
19 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tendler Craig Director 10500 UNIVERSITY CENTER DRIVE, SUITE 110, TAMPA /s/ Dan Dearborn as Power of Attorney for Craig Tendler 17 Feb 2026 0002061924

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HURA Options (Right to Buy) Award $0 +156,240 $0.000000 156,240 12 Feb 2026 Common Stock 156,240 $1.29 Direct F1
holding HURA Options (Right to Buy) 151,883 12 Feb 2026 Common Stock 151,883 $1.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an annual option grant under the TuHURA Biosciences, Inc. 2024 Equity Incentive Plan. One-third of the stock options become exercisable on the first, second, and third anniversaries of February 12, 2026.
F2 Represents an annual option grant under the TuHURA Biosciences, Inc. 2024 Equity Incentive Plan previously granted on March 10, 2025. One-third of the stock options become exercisable on the first, second, and third anniversaries of March 10, 2025.